NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Microbot Medical Inc. (MBOT) Stock Analysis

Microbot Medical Inc. (MBOT) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

MBOT

$0.94

−$0.01 (−0.78%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MBOT with… →

MBOT Key Statistics

As of Oct 21, 2026
Trading
Open
$0.98
Previous Close
$0.95
Day's Range
0.94–0.98
52-Week Range
0.93–2.86
Volume
481.79K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.05
Valuation
Market Cap
$63.14M
P/E Ratio
unprofitable
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.70
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
182.49
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.25
Financials (FY)
Revenue (FY)
$0.00
Net Income (FY)
−$13.14M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
67.16M
1-Year Return
−64.79%
Dividend and dates
Avg Volume
662.89K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, MBOT closed at $0.94, −64.79% over 1 year.

Microbot Medical Inc. (MBOT) has a market capitalization of $63.14M.

In fiscal 2025, MBOT reported revenue of $0.00.

MBOT Stock Return by Calendar Year

Microbot Medical Inc. (MBOT) 10-year return: what $10,000 became

1 year
$10,000 $3,521
−64.79%
5 years
$10,000 $1,291
−87.09%
10 years
$10,000 $77
−99.23%

If you had invested $10,000 in Microbot Medical Inc. (MBOT) 10 years ago, at the close on October 21, 2016, it would have been worth $77 at the close on October 21, 2026: −99.23% in total, −38.57% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−52.99%
2025+78.57%
2024−31.71%
2023−45.51%
2022−59.87%
2021+8.85%
2020−32.25%
2019+491.28%
2018−88.76%
2017−83.28%
2016 (partial year)+78.36%

As of October 21, 2026.

MBOT Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$0.00−$13.14M—
2024$0.00−$11.44M—
2023$0.00−$10.74M—
2022$0.00−$13.17M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$0.00—−$14.74M−$13.14M—
2024$0.00—−$11.63M−$11.44M—
2023$0.00—−$10.14M−$10.74M—
2022$0.00—−$13.44M−$13.17M—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

MBOT Valuation vs Medical Devices Median

Median of 145 stocks
MetricMBOTMedical Devices medianvs median
P/S ratio182.492.5372.1x the median

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Microbot Medical Inc. (MBOT) at $63.14M. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 43 employees.

Over the past 52 weeks the price has ranged from $0.93 to $2.86. MBOT last closed at $0.94 on October 21, 2026. That is −$0.01 (−0.78%) against the previous close. The latest close sits 1.09% above that 52-week low.

Financial Health

In fiscal 2025, Microbot Medical Inc. reported revenue of $0.00. The same year closed with a net loss of $13.14M. Trailing earnings per share are −0.25.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.7. The price-to-sales ratio is 182.49. On price-to-sales that is 72.1 times the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is −64.79%. Across 10 years the annualized return works out at −38.57%. The reported beta is 1.05. Daily returns over the trailing 10 years annualize to a volatility of 151.36%.

Growth & Income

No dividend is on file for MBOT.

So far in 2026 the total return is −52.99%. The strongest complete calendar year on file is 2019 at +491.28%; the weakest is 2018 at −88.76%. Of the 9 complete calendar years on file, 3 finished higher.

Peer Comparison

Microbot Medical Inc. (MBOT) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Microbot Medical Inc. MBOT $63.14M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Microbot Medical Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Microbot Medical Inc.

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices, such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Visit website →